Clinical Trials · NCT00732147

Effects of Pramlintide on Endogenous Production of Very-low-density-lipoprotein (VLDL)-Triglyceride and Glucose in the Post Prandial State in T2DM

Name: Effects of Pramlintide on Endogenous Production of Very-low-density-lipoprotein (VLDL)-Triglyceride and Glucose in the Post Prandial State in T2DM
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

WithdrawnN/APramlintide

Phase: N/A
Recruitment status: Withdrawn
Sponsor: University of Maryland, Baltimore
Enrollment: 0
Start date: Apr 2009
Locations: See registry
Primary endpoint: Endogenous glucose production

View Pramlintide compound reference